Champions Oncology (CSBR) Other Accumulated Expenses (2021 - 2026)

Champions Oncology (CSBR) has 6 years of Other Accumulated Expenses data on file, last reported at $234000.0 in Q3 2026.

• On a quarterly basis, Other Accumulated Expenses rose 101.72% year-over-year to $234000.0 in Q3 2026; TTM through Jul 2026 was $234000.0, a 101.72% increase from a year earlier, with the FY2026 full-year figure at $79000.0, down 41.48% from the prior year.
• Other Accumulated Expenses for Q3 2026 stood at $234000.0, up from $79000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $234000.0 in Q3 2026 and bottomed at $15000.0 in Q1 2022.
• Historically, Other Accumulated Expenses has averaged $128894.7 across 5 years, with a median of $144000.0 in 2023.
• The widest annual swing landed in 2023, when Other Accumulated Expenses soared 860.0%; it then plunged 49.35% in 2026.
• Year by year, Other Accumulated Expenses stood at $143000.0 in 2022, then grew by 3.5% to $148000.0 in 2023, then gained by 2.03% to $151000.0 in 2024, then tumbled by 35.76% to $97000.0 in 2025, then jumped by 141.24% to $234000.0 in 2026.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $234000.0 in Q3 2026, $79000.0 in Q2 2026, and $78000.0 in Q1 2026.